Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach

Overview of attention for article published in Neurotherapeutics, August 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 8 X users

patent: 10 patents

Citations

dimensions_citation: 120 Dimensions

Readers on

mendeley: 78 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 10 patents that reference this research output.

Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents

Grant US-11639351-B2

United States of America

Benzenesulfonamide compounds and their use as therapeutic agents

Grant US-11325902-B2

United States of America

Benzenesulfonamide compounds and their use as therapeutic agents

Grant US-11299490-B2

United States of America

Benzenesulfonamide compouds and their use as therapeutic agents

Grant US-11174268-B2

United States of America

Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents

Grant US-10981905-B2

United States of America

Benzenesulfonamide compounds and their use as therapeutic agents

Grant US-10815229-B1

United States of America

Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors

Grant US-10752623-B2

United States of America

Benzenesulfonamide compounds and their use as therapeutic agents

Grant US-10745392-B2

United States of America

Benzenesulfonamide compounds and their use as therapeutic agents

Grant US-10662184-B2

United States of America

Benzenesulfonamide compounds and their use as therapeutic agents

Application US-10246453-B2

United States of America